Get started
Author

Ali Çakmakçılar

Observed names: A. Çakmakcilar, Ali Cakmakcilar, Ali ÇAKMAKCILAR, Ali Çakmakcilar, Çakmakcılar, Ali
ORCID: 0000-0002-8512-3207
Observed ORCID: 0000-0002-8512-3207
OpenAlex ID: A5055528519
Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions
2017 · Esra Ciftci, Bulent Turgut, et al. · Nuclear Medicine Communications · 12
Evaluation of Myocardial Perfusion Imaging SPECT Parameters and Pharmacologic Stress Test with Adenosine Versus Coronary Angiography Findings: Are They Diagnostically Concordant?
2019 · Zekiye Hasbek, Seyit Ahmet Ertürk, et al. · Molecular Imaging and Radionuclide Therapy · 7
PDF
Relaciones entre el factor-1α inducido por hipoxia y los parámetros de la PET/TC con 18F-FDG en el cáncer colorrectal
2019 · Z. Hasbek, H. Ozer, et al. · Revista Española de Medicina Nuclear e Imagen Molecular · 3
Relationships between hypoxia induced factor-1α and 18F-FDG PET/CT parameters in colorectal cancer
2019 · Zekiye Hasbek, Hatice Ozer, et al. · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · 3
Association of HIF-1α, VEGF, and p53 expression with 18F-FDC PET/CT metabolic parameters and survival in non–small cell lung cancer
2026 · Çakmakcılar, Ali, Hasbek, Zekiye, et al. · The Injector
PDF
Optimal fixed dose of radioactive iodine in the treatment of Graves' disease: 10 mCi or ≥15 mCi?
2025 · Çakmakcılar, Ali · The Injector
PDF
Serum Galekti̇n-3 Ve Di̇feransi̇ye Ti̇roi̇d Kanser İli̇şki̇si̇
2019 · Tuba ÇANDAR, Zekiye HASBEK, et al. · Bozok Tıp Dergisi
Does hepatic visualisation show residual/metastatic thyroid tissue in differentiated thyroid cancer?
2018 · Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü, Zekiye Hasbek, et al. · The Annals of Clinical and Analytical Medicine
Thyroid Cancer and Galectin-3
2017 · Zekiye Hasbek, Gülhan Duman, et al.
Works count: 9
Citation count: 25
H-index: 3
I10-index: 1
Year
Topic
Type